Santhera Pharmaceuticals Holding AG (0QN1.L) Stock Price
CHF14.58 0%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
3 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Santhera Pharmaceuticals Holding AG, AI stock picks, stock alerts and much more.
0QN1.L AI Stock Analysis
AI stock analysis for 0QN1.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Santhera Pharmaceuticals Holding AG (0QN1.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Santhera Pharmaceuticals Holding AG (0QN1.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Santhera Pharmaceuticals Holding AG (0QN1.L), currently trading at CHF14.58, will... Sign up to access price prediction.
About 0QN1.L
-
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally.
-
Symbol
0QN1.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
189M
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$394.5 0.3% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$142.1 0.9% |
6 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.23 1.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.64 2.1% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.8 2.9% |
6 |
0QN1.L Alternative Data
Web Traffic
Santhera Pharmaceuticals Holding AG receives an estimated 6700 monthly visitors to santhera.com, which is down by -19.2% over the last month.
-
Web Traffic
6700
-
Change from Previous Month
19.2%
-
3 Month Change
25.1%
-
YoY Change
25.1%
Twitter Followers
Santhera Pharmaceuticals Holding AG has 766 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.4% over the last month.
-
Twitter Followers
766
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Facebook Engagement
Santhera Pharmaceuticals Holding AG has engaged 7 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
7
-
Daily Change
41.7%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Youtube Subscribers
Santhera Pharmaceuticals Holding AG has 36 subscribers on its main Youtube channel.
-
Youtube Subscribers
36
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Santhera Pharmaceuticals Holding AG has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Instagram Followers
Santhera Pharmaceuticals Holding AG has 792 Instagram Followers on its main Instagram account, down by -0.6% over the last month.
-
Instagram Followers
792
-
Daily Change
0.1%
-
1 Month Change
0.6%
-
3 Month Change
0.8%
-
YoY Change
0.8%
LinkedIn Followers
21,004 are following Santhera Pharmaceuticals Holding AG on LinkedIn, up by 2% over the last month.
-
LinkedIn Followers
21004
-
Daily Change
2%
-
1 Month Change
2%
-
3 Month Change
6%
-
YoY Change
6%
LinkedIn Employees
According to LinkedIn, Santhera Pharmaceuticals Holding AG has 109 employees, up by 1.9% over the last month.
-
LinkedIn Employees
109
-
Daily Change
1.9%
-
1 Month Change
1.9%
-
3 Month Change
7.9%
-
YoY Change
7.9%
News Mentions
Santhera Pharmaceuticals Holding AG was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0QN1.L Financials
0QN1.L Key Metrics
-
Total Revenue
CHF25M
-
Net Income
-CHF26.7M
-
Earnings per Share
-CHF2.34
-
Free cash flow
-CHF20.3M
-
EBITDA
-CHF1.4M
-
EBITDA Ratio
-0.0559932
-
Total Assets
CHF152.5M
0QN1.L 2-year Revenue & Income
0QN1.L 2-year Free Cash Flow
0QN1.L Technicals
0QN1.L SMA
0QN1.L RSI
FAQ
What's the current price of Santhera Pharmaceuticals Holding AG (0QN1.L) Stock?
The price of an Santhera Pharmaceuticals Holding AG (0QN1.L) share is CHF14.58.
What's the market cap of Santhera Pharmaceuticals Holding AG?
The current market cap of Santhera Pharmaceuticals Holding AG is 189M.
What are some stocks similar to Santhera Pharmaceuticals Holding AG (0QN1.L) that investors often compare it to?
Santhera Pharmaceuticals Holding AG (0QN1.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Santhera Pharmaceuticals Holding AG's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Santhera Pharmaceuticals Holding AG's stock price to be around CHF13.95 in 2026. Starting from the current price of CHF14.58, this represents a 4.3% change in price, indicating a bearish outlook for the stock.
How to buy Santhera Pharmaceuticals Holding AG (0QN1.L) Stock?
Santhera Pharmaceuticals Holding AG stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Santhera Pharmaceuticals Holding AG shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.